Demographics, Diagnosis, Management, and Outcomes of Non-occlusive Mesenteric Ischemia. (NCT06970015) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Demographics, Diagnosis, Management, and Outcomes of Non-occlusive Mesenteric Ischemia.
Estonia566 participantsStarted 2022-06-06
Plain-language summary
This prospective multicenter observational study, conducted between June , 2022, and April, 2023, is a preplanned analysis of the AMESI study titled 'Demographics, diagnosis, management, and outcomes of non-occlusive mesenteric ischemia,' aiming primarily to describe the demographic profile, clinical presentation, and laboratory findings of patients with non-occlusive mesenteric ischemia (NOMI), and secondarily to identify independent risk factors as well as diagnostic approaches, management strategies, and outcomes-including in-hospital, 90-day, and one-year results.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
All at least 18-year-old patients with acute mesenteric ischemia or patients suspected of acute mesenteric ischemia that was not confirmed
* Patients with arterial occlusive AMI
* Patients with non-occlusive mesenteric ischemia
* Patients with venous occlusive AMI
* Patients with unclear mechanism of AMI
* Patients with suspected but not confirmed AMI
Exclusion Criteria:
* Patients with other specific form of AMI (e.g dissection)
* Confirmed strangulating bowel obstruction
* Individuals under 18 years of age.
* Consent declined by patient or next of kin
* Chronic mesenteric ischaemia without an acute event
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Demographic profile
Timeframe: Baseline
2
SOFA score
Timeframe: Baseline
3
Serum Lactate Levels in Patients with Non-Occlusive Mesenteric Ischemia
Timeframe: Baseline
4
Baseline APACHE II Score
Timeframe: Baseline
5
Arterial Blood pH in Patients with Non-Occlusive Mesenteric Ischemia